FDA — authorised 27 December 1995
- Marketing authorisation holder: CONCORDIA LABS INC
- Status: approved
🇺🇸 Photofrin in United States
FDA authorised Photofrin on 27 December 1995
Marketing authorisations
FDA — authorised 1 August 2003
- Application: NDA021525
- Marketing authorisation holder: AXCAN SCANDIPHARM
- Local brand name: PHOTOFRIN
- Indication: Injectable — Injection
- Status: approved
Photofrin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Photofrin approved in United States?
Yes. FDA authorised it on 27 December 1995; FDA authorised it on 1 August 2003.
Who is the marketing authorisation holder for Photofrin in United States?
CONCORDIA LABS INC holds the US marketing authorisation.